Topics:

Kaiser Permanente to Evaluate Neopath's AutoPap 300 QC System

Kaiser Permanente to Evaluate Neopath's AutoPap 300 QC System

REDMOND, Wash--NeoPath Inc has signed an agreement with Kaiser Permanente to install AutoPap 300 QC Systems at its Northern California facility. Following a successful evaluation, Kaiser Permanente anticipates making the technology available to its nearly 2.5 million Northern California members.

The AutoPap System rescreens Pap smear slides initially classified as normal, using high-speed image processing computers, video imaging technology, and image interpretation software. In clinical trials in US laboratories, the system improved the detection rate of false-negative smears.

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.